Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

New research is helping develop better treatments for alopecia areata.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The Asiatic lion has very low genetic diversity and unique genetic traits, highlighting the need for its conservation.

Blocking Prostaglandin D₂ may help treat hair loss.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

A group has developed therapies that show promise for treating cancer and various other conditions.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.